Astragalus mongholicus Bunge (Fabaceae): Bioactive Compounds and Potential Therapeutic Mechanisms Against Alzheimer's Disease
- PMID: 35837291
- PMCID: PMC9273815
- DOI: 10.3389/fphar.2022.924429
Astragalus mongholicus Bunge (Fabaceae): Bioactive Compounds and Potential Therapeutic Mechanisms Against Alzheimer's Disease
Abstract
Astragalus mongholicus Bunge (Fabaceae) (also known as Astragali radix-AR), a widely used herb by Traditional Chinese Medicine practitioners, possesses a wide range of pharmacological effects, and has been used to treat Alzheimer's disease (AD) historically. Its bioactive compounds are categorized into four families: saponins, flavonoids, polysaccharides, and others. AR's bioactive compounds are effective in managing AD through a variety of mechanisms, including inhibiting Aβ production, aggregation and tau hyperphosphorylation, protecting neurons against oxidative stress, neuroinflammation and apoptosis, promoting neural stem cell proliferation and differentiation and ameliorating mitochondrial dysfunction. This review aims to shed light upon the chemical constituents of AR and the mechanisms underlying the therapeutic effect of each compound in manging AD. Also presented are clinical studies which reported successful management of AD with AR and other herbs. These will be helpful for drug development and clinical application of AR to treat AD.
Keywords: Astragali radix; alzheimer’s disease; bioactive compound; molecular mechanism; traditional Chinese medicine.
Copyright © 2022 Dong, Li, Zhang, Hu, Liang and Xiong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Exploration of the main effective constituent and the mechanism in Astragali Radix in the treatment for doxorubicin-induced nephropathy by integrating metabolomics and molecular docking.J Ethnopharmacol. 2023 Apr 6;305:116074. doi: 10.1016/j.jep.2022.116074. Epub 2022 Dec 25. J Ethnopharmacol. 2023. PMID: 36577490
-
Research progress of natural medicine Astragalus mongholicus Bunge in treatment of myocardial fibrosis.J Ethnopharmacol. 2023 Apr 6;305:116128. doi: 10.1016/j.jep.2022.116128. Epub 2023 Jan 6. J Ethnopharmacol. 2023. PMID: 36623754 Review.
-
The Antioxidant Action of Astragali radix: Its Active Components and Molecular Basis.Molecules. 2024 Apr 9;29(8):1691. doi: 10.3390/molecules29081691. Molecules. 2024. PMID: 38675511 Free PMC article. Review.
-
Exploratory review on the effect of Astragalus mongholicus on signaling pathways.Front Pharmacol. 2024 Dec 11;15:1510307. doi: 10.3389/fphar.2024.1510307. eCollection 2024. Front Pharmacol. 2024. PMID: 39726784 Free PMC article. Review.
-
Evaluation of the Pharmaceutical Properties and Value of Astragali Radix.Medicines (Basel). 2018 May 21;5(2):46. doi: 10.3390/medicines5020046. Medicines (Basel). 2018. PMID: 29883402 Free PMC article. Review.
Cited by
-
Identifying the Anti-inflammatory Effects of Astragalus Polysaccharides in Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Network Pharmacology and Experimental Validation.Comb Chem High Throughput Screen. 2024;27(7):1022-1032. doi: 10.2174/1386207326666230816162113. Comb Chem High Throughput Screen. 2024. PMID: 37587811
-
Effect of acupuncture on neuroinflammation in animal models of Alzheimer's disease: A preclinical systematic review and meta-analysis.Front Aging Neurosci. 2023 Mar 1;15:1110087. doi: 10.3389/fnagi.2023.1110087. eCollection 2023. Front Aging Neurosci. 2023. PMID: 36936500 Free PMC article.
-
The role of Phosphodiesterase-1 and its natural product inhibitors in Alzheimer's disease: A review.Front Pharmacol. 2022 Dec 21;13:1070677. doi: 10.3389/fphar.2022.1070677. eCollection 2022. Front Pharmacol. 2022. PMID: 36618909 Free PMC article. Review.
-
Targeting microglia polarization with Chinese herb-derived natural compounds for neuroprotection in ischemic stroke.Front Cell Dev Biol. 2025 Jun 10;13:1580479. doi: 10.3389/fcell.2025.1580479. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40556734 Free PMC article. Review.
-
Research Progress on the Treatment of Related Diseases With Astragalus.Drug Des Devel Ther. 2025 Apr 12;19:2845-2862. doi: 10.2147/DDDT.S494915. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40248273 Free PMC article. Review.
References
-
- Abdalla F. H., Cardoso A. M., Pereira L. B., Schmatz R., Gonçalves J. F., Stefanello N., et al. (2013). Neuroprotective Effect of Quercetin in Ectoenzymes and Acetylcholinesterase Activities in Cerebral Cortex Synaptosomes of Cadmium-Exposed Rats. Mol. Cell. Biochem. 381 (1-2), 1–8. 10.1007/s11010-013-1659-x - DOI - PubMed
-
- Abdalla F. H., Schmatz R., Cardoso A. M., Carvalho F. B., Baldissarelli J., de Oliveira J. S., et al. (2014). Quercetin Protects the Impairment of Memory and Anxiogenic-like Behavior in Rats Exposed to Cadmium: Possible Involvement of the Acetylcholinesterase and Na(+),K(+)-ATPase Activities. Physiol. Behav. 135, 152–167. 10.1016/j.physbeh.2014.06.008 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials